BioAge Labs

About

BioAge Labs is a US-based biotechnology company focused on developing therapeutics for cardiometabolic diseases by targeting the biological processes of aging. Their core technology is a human-first discovery platform that leverages decades of proprietary multi-omics data to identify and validate novel aging-related drug targets. Currently, BioAge is advancing BGE-102, a program targeting chronic inflammation, and a preclinical apelin receptor agonist with potential for significant weight loss, both aimed at addressing age-related metabolic dysfunction.

Focus Areas

Technology Focus

Key People 1

• K Kristen Fortney